Category: Article
   
   Advancing Ovarian Cancer Therapies: Clinical Research Trends, Challenges, and Proven Strategies  In “Advancing Ovarian Cancer Therapies: Clinical Research Trends, Challenges, and Proven Strategies,” Susan Albert, VP  Read Now   
   Optimizing Global Early-phase Oncology Trials  Strategies for Success  The clinical trial landscape is constantly evolving, particularly in oncology early development,  Read Now   
   Traditional Site Networks Are Broken  Building Real Site Relationships to Facilitate the Success of Early Phase Oncology Trials Oncology clinical  Read Now   
   Catalyst Flex Excels as an Adaptable, Comprehensive FSP  The biopharmaceutical industry increasingly turns to Catalyst Flex for its unique approach to functional service  Read Now   
   Benefits of Working with Catalyst Oncology versus a Large Generalist CRO  Oncology drug development continues to increase in its complexity. Large contract research organizations (CROs) are  Read Now   
   Expanding Clinical Trial Diversity: A Catalyst Values Approach  “Today, overall cancer clinical trial enrollment in the United States is 8% (6.3%‐7.0% at community  Read Now   
   A Reflection on the European Regulatory Framework  Historically gaining regulatory approval across multiple countries within the European Union (EU) was segmented, excessively  Read Now